🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🦿Incredible day today at HUG - Hopitaux Universitaires de Genève for the expert group discussion on PJIs 👩🏻‍⚕️Greatful for the learning opportunity from such an amazing group of clinical experts!

🌎 Do you know where R&D takes place for ABs and antibacterial agents? 🧫 Over 90% ABs at development takes place in HIC (84%) and UMICs (12%) 🔬 Only 4 products are being developed in LMICs 👉 Read our full report here: lnkd.in/dU4Gnxb7

Horrifying anecdote on superbugs in Ukraine: Doctors found six XDR strains in his blood and tissues. Sequencing the pathogens...they identified a pandrug-resistant Klebsiella equipped with NDM-1 and 23 other resistance genes #AMR science.org/content/articl… via Science Magazine

Modern Warfare Is Breeding Deadly Superbugs. Why? War fuels AMR and we must stop both. 👏 Read this fantastic article on by @FrancescaMari featuring Souha Kanj, Omar Dewachi, Ghassan Abu Sitta and my research work at World Health Organization (WHO) nytimes.com/2024/11/26/mag…

"superbugs are jumping from soldiers injured in the field to civilians receiving care for conditions entirely unrelated to the war," writes Eli Cahan in a piece for Rolling Stone exploring the troubling synergies between armed conflict and #AMR . rollingstone.com/politics/polit…

Please join us next March 4 for this upcoming webinar on Investigating and developing better antibiotics for children: What Can We Do Now and Next? Martina Penazzato @YasirBinNisar Cécile Ollivier Global Antibiotic R&D Partnership (GARDP) CHAI

💢 Are you developing an IVD test? This is for you! 🔎 The EU committed~ EUR 13 million to speed up the development of a point-of-care IVD (results <1h) 🍄+🦠 👇 More information below 📅 Deadline : 12.05.2025 EU HERA HaDEA #IVD #AMR ec.europa.eu/info/funding-t…

Indeed we welcome advancements in R&D to curb AMR! I hope this program will open up the way to many other innovations against difficult to treat life-threatening infections We need more investments in new antibiotics as societal commitment to global health security